Intracerebroventricular delivery of self-complementary adeno-associated virus serotype 9 to the adult rat brain

Gene Therapy

Volumn 23, Issue 5, 2016, Pages 401-407

  Donsante, A ^a   McEachin, Z ^a   Riley, J ^a   Leung, C H ^b   Kanz, L ^b   O'Connor, D M ^a   Boulis, N M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WIDENER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS 9; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DORSAL STRIATUM; DRUG MEGADOSE; EXPERIMENTAL PIG; GENETIC TRANSDUCTION; HIPPOCAMPUS; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; SPINAL CORD TRANSSECTION; THALAMUS; VIRAL GENE DELIVERY SYSTEM; ANIMAL; DEPENDOPARVOVIRUS; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; GLIOSIS; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; MOUSE; NERVE CELL; PIG; SEROTYPE;

ANIMALS; ASTROCYTES; CEREBELLUM; CEREBRAL CORTEX; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; GLIOSIS; HIPPOCAMPUS; HUMANS; INFUSIONS, INTRAVENTRICULAR; MICE; NEURONS; RATS; SEROGROUP; SWINE; TRANSDUCTION, GENETIC;

EID: 84959177981     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2016.6     Document Type: Article

References (28)

1. Gray SJ, Nagabhushan Kalburgi S, McCown TJ, Jude Samulski R. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Therapy 2013; 20: 450-459.
2. Mingozzi F, High KA. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 2013; 122: 23-36.
3. Ellinwood NM, Ausseil J, Desmaris N, Bigou S, Liu S, Jens JK et al. Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes. Mol Ther 2011; 19: 251-259.
4. Dayton RD, Wang DB, Klein RL. The advent of AAV9 expands applications for brain and spinal cord gene delivery. Expert Opin Biol Ther 2012; 12: 757-766.
5. McLean JR, Smith GA, Rocha EM, Hayes MA, Beagan JA, Hallett PJ et al. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection. Neurosci Lett 2014; 576: 73-78.
6. Levites Y, Jansen K, Smithson LA, Dakin R, Holloway VM, Das P et al. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. J Neurosci 2006; 26: 11923-11928.
7. Gholizadeh S, Tharmalingam S, Macaldaz ME, Hampson DR. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice. Hum Gene Ther Methods 2013; 24: 205-213.
8. Dirren E, Towne CL, Setola V, Redmond Jr DE, Schneider BL, Aebischer P. Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord. Hum Gene Ther 2014; 25: 109-120.
9. Chakrabarty P, Rosario A, Cruz P, Siemienski Z, Ceballos-Diaz C, Crosby K et al. Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS One 2013; 8: e67680.
10. Broekman ML, Baek RC, Comer LA, Fernandez JL, Seyfried TN, Sena-Esteves M. Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery. Mol Ther 2007; 15: 30-37.
11. Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 2011; 365: 2357-2365.
12. Haurigot V, Marco S, Ribera A, Garcia M, Ruzo A, Villacampa P et al. Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy. J Clin Invest 2013; 123: 3254-3271.
13. Bastianelli E. Distribution of calcium-binding proteins in the cerebellum. Cerebellum 2003; 2: 242-262.
14. Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR et al. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther 2012; 23: 382-389.
15. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010; 119: 7-35.
16. Benesova J, Hock M, Butenko O, Prajerova I, Anderova M, Chvatal A. Quantification of astrocyte volume changes during ischemia in situ reveals two populations of astrocytes in the cortex of GFAP/EGFP mice. J Neurosci Res 2009; 87: 96-111.
17. Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F et al. Uniquely hominid features of adult human astrocytes. J Neurosci 2009; 29: 3276-3287.
18. McCarty DM. Self-complementary AAV vectors; advances and applications. Mol Ther 2008; 16: 1648-1656.
19. McCarty DM, Monahan PE, Samulski RJ. Self-complementary recombinant adenoassociated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Therapy 2001; 8: 1248-1254.
20. McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, Samulski RJ. Adenoassociated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Therapy 2003; 10: 2112-2118.
21. Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Therapy 2003; 10: 2105-2111.
22. Nathwani AC, Gray JT, Ng CY, Zhou J, Spence Y, Waddington SN et al. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 2006; 107: 2653-2661.
23. Fontana A, Fierz W, Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984; 307: 273-276.
24. Samaranch L, San Sebastian W, Kells AP, Salegio EA, Heller G, Bringas JR et al. AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigenpresenting cell transduction. Mol Ther 2014; 22: 329-337.
25. Hollak CE, Wijburg FA. Treatment of lysosomal storage disorders: successes and challenges. J Inherit Metab Dis 2014; 37: 587-598.
26. Sands MS, Davidson BL. Gene therapy for lysosomal storage diseases. Mol Ther 2006; 13: 839-849.
27. Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 2004; 10: 816-820.
28. Costa Mdo C, Luna-Cancalon K, Fischer S, Ashraf NS, Ouyang M, Dharia RM et al. Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease. Mol Ther 2013; 21: 1898-1908.